FSD Pharma Inc. filed a Form 6-K on April 30, 2024, reporting compliance with SEC rules, confirming it will file annual reports under Form 20-F. The event is neutral in sentiment and not significant from an equity investor's perspective.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.